Nazareno Carullo

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Childhood Obesity: Insight into Kidney Involvement

Nazareno Carullo, Mariateresa Zicarelli, Ashour Michael et al. · International Journal of Molecular Sciences · 2023 · 25 citations · Full text

Metabolic Disorder, New Biomarkers, Obesity +18

Evaluation of arteriovenous fistula for hemodialysis with a new generation digital stethoscope: a pilot study

Pierangela Presta, Nazareno Carullo, Annarita Armeni et al. · International Urology and Nephrology · 2023 · 11 citations